Individuals Coming Off Slimming Medications Put On Pounds Four Times Faster Than Those on Conventional Diets

Fresh analysis reveals that people who discontinue blockbuster slimming jabs like Mounjaro or Wegovy tend to recover shed pounds much more quickly than those who stop traditional lifestyle programs.

Research printed in a leading health publication points out that while obese people often shed substantial amounts of their body weight while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month after stopping.

"Individuals buying these treatments should be aware of the risk of rapid weight regain when the treatment concludes," warns researcher Dr. Susan Jebb.

This pace of regain implies a reversion to starting mass in about a year and a half.

Comparing Approaches

The research, which reviewed 37 of studies involving over 9,000 of participants, compared the outcomes of the injectable medications with older methods.

Researchers point out that individuals who lose weight through dieting generally have a slower weight regain—around 100 grams monthly—after stopping.

Explaining the Quick Rebound

Experts believe the way of the drugs is key to understanding the heightened rebound.

GLP-1 drugs imitate a natural hormone called GLP-1, which helps regulate appetite.

"Long-term administration of GLP-1 concentrations far above than normal could lead to the body to produce less of its endogenous hormone, and could reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this hormone supplement leads to appetite is unsuppressed, making overeating far more likely."

A Lifelong Disease?

The NHS recommend the jabs for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.

Professionals say that, considering the significant potential of relapse, the treatment might need to be ongoing.

This view is reinforced by pharmaceutical companies, who say that the findings "highlight the chronic character of excess weight," similar to managing conditions like diabetes.

User Testimonies

People who have come off the jabs describe a powerful return of cravings.

"It felt as if a switch that goes on and you become starving," said a patient.

The struggle is compounded if patients have not established lasting dietary or behavioural modifications during treatment.

Widespread Adoption

Survey data show that millions of people in the UK have used these injections in the past year, with demand remaining high.

• Use is greater among women than males.
• The 40s and 50s demographic shows the greatest level of interest.
• A large proportion access the drugs through private healthcare rather than the NHS.

In conclusion, researchers stress that while these medications are powerful tools for weight loss, they are not a permanent cure and long-term success relies on combined lifestyle changes.